U.S. Senate · 118th Congress · S. 4426
Promising Pathway Act 2.0
A bill to amend the Federal Food, Drug, and Cosmetic Act to establish a time-limited conditional approval pathway, subject to specific obligations, for certain drugs and biological products, and for other purposes.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Mike BraunR-IN
- Introduced
- May 23, 2024, in the Senate
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (11)
6 Democrats, 5 Republicans. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Cory A. BookerD-NJ
- Kevin CramerR-ND
- Kirsten E. GillibrandD-NY
- Josh HawleyR-MO
- Joe Manchin, IIID-WV
- Lisa MurkowskiR-AK
- Alex PadillaD-CA
- Eric SchmittR-MO
- J.D. VanceR-OH
- Peter WelchD-VT
Signed on later
- Richard J. DurbinD-ILSeptember 12, 2024